feed,title,long_url,short_url
ğŸ”MarketWatch,CytomX Therapeutics stock price target cut to $4 from $16 at Mizuho,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=CTMX&siteid=rss,https://on.mktw.net/3yk6W1f
ğŸ”MarketWatch,Cerevel Therapeutics started at neutral with $30 stock price target at Mizuho,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=CERE&siteid=rss,https://on.mktw.net/32Oo5Ek
ğŸ”MarketWatch,Harmony Biosciences started at buy with $64 stock price target at Mizuho,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=HRMY&siteid=rss,https://on.mktw.net/3lqLzp9
ğŸ”MarketWatch,BioXcel Therapeutics started at buy with $19 stock price target at Mizuho,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=BTAI&siteid=rss,https://on.mktw.net/3uxF9sZ
ğŸ”MarketWatch,Athira Pharma started at buy with $6 stock price target at Mizuho,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=ATHA&siteid=rss,https://on.mktw.net/3ynpQ7j
